Global Endometriosis Market Size was estimated at USD 1517.37 million in 2022 and is projected to reach USD 1674.82 million by 2028, exhibiting a CAGR of 1.41% during the forecast period.
Global Endometriosis Market Overview:
Global Endometriosis Market Report 2022 comes with the extensive industry analysis with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Endometriosis involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Endometriosis Market
The Endometriosis Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Endometriosis Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Endometriosis Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on Endometriosis Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Endometriosis market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global Endometriosis Market Segmentation
Global Endometriosis Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, Endometriosis market has been segmented into:
Gonadotropins Releasing Hormone Agonists
Non-Steroidal Anti-Inflammatory Drugs
Progestin
Oral Contraceptive Pills
By Application, Endometriosis market has been segmented into:
Hospital Use
Clinic Use
Other
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Endometriosis market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Endometriosis market.
Top Key Players Covered in Endometriosis market are:
AbbVie
AstraZeneca
Bayer HealthCare
Pfizer
Addex Therapeutics
Astellas Pharma
Debiopharm
ElexoPharm
EndoCeutics
Euroscreen
Forendo Pharma
Kissei Pharmaceutical
Neurocrine Biosciences
Nippon Shinyaku
Takeda
Bayer AG
Neurocrine Biosciences
Objective to buy this Report:
1. Endometriosis analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Endometriosis market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Endometriosis Market by Type
5.1 Endometriosis Market Overview Snapshot and Growth Engine
5.2 Endometriosis Market Overview
5.3 Gonadotropins Releasing Hormone Agonists
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2028F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Gonadotropins Releasing Hormone Agonists: Geographic Segmentation
5.4 Non-Steroidal Anti-Inflammatory Drugs
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2028F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Non-Steroidal Anti-Inflammatory Drugs: Geographic Segmentation
5.5 Progestin
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2028F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Progestin: Geographic Segmentation
5.6 Oral Contraceptive Pills
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2016-2028F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Oral Contraceptive Pills: Geographic Segmentation
Chapter 6: Endometriosis Market by Application
6.1 Endometriosis Market Overview Snapshot and Growth Engine
6.2 Endometriosis Market Overview
6.3 Hospital Use
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2028F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospital Use: Geographic Segmentation
6.4 Clinic Use
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2028F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Clinic Use: Geographic Segmentation
6.5 Other
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2028F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Other: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Endometriosis Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Endometriosis Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Endometriosis Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 ABBVIE
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 ASTRAZENECA
7.4 BAYER HEALTHCARE
7.5 PFIZER
7.6 ADDEX THERAPEUTICS
7.7 ASTELLAS PHARMA
7.8 DEBIOPHARM
7.9 ELEXOPHARM
7.10 ENDOCEUTICS
7.11 EUROSCREEN
7.12 FORENDO PHARMA
7.13 KISSEI PHARMACEUTICAL
7.14 NEUROCRINE BIOSCIENCES
7.15 NIPPON SHINYAKU
7.16 TAKEDA
7.17 BAYER AG
7.18 NEUROCRINE BIOSCIENCES
Chapter 8: Global Endometriosis Market Analysis, Insights and Forecast, 2016-2028
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Gonadotropins Releasing Hormone Agonists
8.2.2 Non-Steroidal Anti-Inflammatory Drugs
8.2.3 Progestin
8.2.4 Oral Contraceptive Pills
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospital Use
8.3.2 Clinic Use
8.3.3 Other
Chapter 9: North America Endometriosis Market Analysis, Insights and Forecast, 2016-2028
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Gonadotropins Releasing Hormone Agonists
9.4.2 Non-Steroidal Anti-Inflammatory Drugs
9.4.3 Progestin
9.4.4 Oral Contraceptive Pills
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospital Use
9.5.2 Clinic Use
9.5.3 Other
9.6 Historic and Forecast Market Size by Country
9.6.1 U.S.
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Europe Endometriosis Market Analysis, Insights and Forecast, 2016-2028
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Gonadotropins Releasing Hormone Agonists
10.4.2 Non-Steroidal Anti-Inflammatory Drugs
10.4.3 Progestin
10.4.4 Oral Contraceptive Pills
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospital Use
10.5.2 Clinic Use
10.5.3 Other
10.6 Historic and Forecast Market Size by Country
10.6.1 Germany
10.6.2 U.K.
10.6.3 France
10.6.4 Italy
10.6.5 Russia
10.6.6 Spain
10.6.7 Rest of Europe
Chapter 11: Asia-Pacific Endometriosis Market Analysis, Insights and Forecast, 2016-2028
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Gonadotropins Releasing Hormone Agonists
11.4.2 Non-Steroidal Anti-Inflammatory Drugs
11.4.3 Progestin
11.4.4 Oral Contraceptive Pills
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospital Use
11.5.2 Clinic Use
11.5.3 Other
11.6 Historic and Forecast Market Size by Country
11.6.1 China
11.6.2 India
11.6.3 Japan
11.6.4 Singapore
11.6.5 Australia
11.6.6 New Zealand
11.6.7 Rest of APAC
Chapter 12: Middle East & Africa Endometriosis Market Analysis, Insights and Forecast, 2016-2028
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Gonadotropins Releasing Hormone Agonists
12.4.2 Non-Steroidal Anti-Inflammatory Drugs
12.4.3 Progestin
12.4.4 Oral Contraceptive Pills
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospital Use
12.5.2 Clinic Use
12.5.3 Other
12.6 Historic and Forecast Market Size by Country
12.6.1 Turkey
12.6.2 Saudi Arabia
12.6.3 Iran
12.6.4 UAE
12.6.5 Africa
12.6.6 Rest of MEA
Chapter 13: South America Endometriosis Market Analysis, Insights and Forecast, 2016-2028
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Gonadotropins Releasing Hormone Agonists
13.4.2 Non-Steroidal Anti-Inflammatory Drugs
13.4.3 Progestin
13.4.4 Oral Contraceptive Pills
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospital Use
13.5.2 Clinic Use
13.5.3 Other
13.6 Historic and Forecast Market Size by Country
13.6.1 Brazil
13.6.2 Argentina
13.6.3 Rest of SA
Chapter 14 Investment Analysis
Chapter 15 Analyst Viewpoint and Conclusion
Publisher: Introspective Market Research
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support
Frequently Asked Questions (FAQ)
Global Endometriosis Market Size was estimated at USD 1517.37 million in 2022 and is projected to reach USD 1674.82 million by 2028.
AbbVie, AstraZeneca, Bayer HealthCare, Pfizer, Addex Therapeutics, Astellas Pharma, Debiopharm, ElexoPharm, EndoCeutics, Euroscreen, Forendo Pharma, Kissei Pharmaceutical, Neurocrine Biosciences, Nippon Shinyaku, Takeda, Bayer AG, Neurocrine Biosciences
North America,Europe,Asia-Pacific,South America,Middle East & Africa